Antagonism of tumour necrosis factor α in refractory asthma

Berry, Mike A.; Pavord, Ian D.
July 2008
Thorax;Jul2008, Vol. 63 Issue 7, p571
Academic Journal
The author reflects on the antagonism of tumor necrosis factor in α in refractory asthma. He states that asthma that is refractory to treatment with inhaled corticosteroids affects 5-10 percent of patients with asthma. The author further states that the rationale for investigating the role of TNFα in refractory asthma is strong.


Related Articles

  • Evaluation of the left and right ventricular systolic and diastolic function in asthmatic children. Akyüz Özkan, Esra; Khosroshahi, Hashem E. // BMC Cardiovascular Disorders;7/8/2016, Vol. 16, p1 

    Background: Asthma is the most common cause of respiratory disorders among children. We aimed to investigate left (LV) and right (RV) ventricular function in asthmatic children as detected by conventional and tissue Doppler echocardiography.Methods: Fifty pediatric...

  • Is there more than one inflammatory phenotype is asthma? O'Donnell, R. A.; Frew, A. J. // Thorax;Jul2002, Vol. 57 Issue 7, p566 

    The article discusses whether there is more than one inflammatory phenotype in asthma. But there are some problems in asthma investigations. Most asthmatic patients recruited to these studies either had severe disease or were on some form of corticosteroid therapy, raising concerns about...

  • For the Patient.  // Allergy & Asthma Proceedings;Sep/Oct2013, Vol. 34 Issue 5, p480 

    The article presents an overview of the study which examined the effects of inhaled corticosteroid (ICS) on patients with persistent asthma. The study cited the views of the U.S. Food and Drug Administration (FDA) that ICS caused growth inhibition in children. The researchers reviewed ICS...

  • Asthma. Pinnock, Hilary; Shah, Rupal // BMJ: British Medical Journal (International Edition);4/21/2007, Vol. 334 Issue 7598, p847 

    The article reports on asthma treatment, diagnosis and management in Great Britain. A series of guidelines are provided on how a health service professional should best assist a patient who suffers from asthma. 5.8% of the population in Great Britain suffers from asthma and 1500 deaths result...

  • Inhaled corticosteroids moderate lung function decline in adults with asthma. Ernst, P. // Thorax;Feb2006, Vol. 61 Issue 2, p93 

    The paper describes a reduction in the decline in forced expiratory volume in 1 second (FEV1) over 10 years in patients with asthma aged over 30 years who were using inhaled corticosteroids throughout the observation period. Lange and colleagues conducted the study using information from the...

  • Inhaled corticosteroids did not increase nonvertebral fractures in adults with asthma or chronic obstructive pulmonary disease. Thien, Frank // ACP Journal Club;Jul/Aug2005, Vol. 143 Issue 1, p53 

    This article presents information on a study describing the risk of nonvertebral fracture related to inhaled corticosteroid (ICSs) exposure among adults with chronic respiratory disease. In adults with asthma, chronic obstructive pulmonary disease, or both, short-term use of inhaled...

  • Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskusâ„¢ or Pressurised Metered-Dose Inhaler in Children with Asthma. Bracamonte, Teresa; Schauer, Uwe; Emeryk, Andrzej; Godwood, Alex; Balsara, Sima // Clinical Drug Investigation;2005, Vol. 25 Issue 1, p1 

    Background and objective: Salmeterol and fluticasone propionate are well established in the treatment of childhood asthma, and their combination is effective in children aged 4–11 years. Asthma guidelines recommend that the inhaler device best suited to the individual should be used to...

  • Dose response of patients to oral corticosteroid treatment during exacerbations of asthma. Webb, Jonathan R. // British Medical Journal (Clinical Research Edition);4/19/1986, Vol. 292 Issue 6527, p1045 

    Examines the reactions of asthmatic patients to oral corticosteroid management. Importance of doubling the dosage of prednisolone; Mechanism of corticosteroid treatment; Dependence of the course of response to the clinical state of the patient.

  • Systemic Availability of Inhaled Budesonide and Fluticasone Propionate: Healthy versus Asthmatic Lungs. Harrison, T.W. // BioDrugs;2001, Vol. 15 Issue 6, p405 

    Inhaled corticosteroids are now recommended for the majority of patients with asthma. Although their therapeutic ratio is superior to that of oral corticosteroids, their long term use is associated with several potentially important adverse effects. A number of studies have compared the efficacy...


Read the Article


Sign out of this library

Other Topics